Autophagy inhibition sensitizes radiotherapy responses in high-grade mutant IDH1 glioma.

Inhibiting autophagy with ATG7 silencing nanoparticles enhances radiotherapy effectiveness in high-grade mutant IDH1 gliomas, leading to tumor regression and long-term survival.

• Why it matters: High-grade gliomas with mutant IDH1 are resistant to conventional treatments due to metabolic reprogramming, creating a need for targeted strategies to improve therapy outcomes.
• What they did: The study used RNA-sequencing, single-cell analysis, and ChIP-seq to identify autophagy upregulation in mIDH1 gliomas and employed synthetic nanoparticles delivering ATG7 silencing RNA to inhibit autophagy.
• The result: Autophagy inhibition sensitized glioma cells to radiation, causing tumor shrinkage and durable immune responses, highlighting autophagy as a key survival pathway and a promising therapeutic target.